Is interleukin-4δ3 splice variant expression in bovine tuberculosis a marker of protective immunity?

Infection and Immunity

Volumn 75, Issue 6, 2007, Pages 3006-3013

  Rhodes, Shelley G ^a   Sawyer, Jason ^a   Whelan, Adam O ^a   Dean, Gillian S ^a   Coad, Michael ^a   Ewer, Katie J ^a   Waldvogel, Andreas S ^b   Zakher, Anthony ^b   Clifford, Derek J ^a   Hewinson, R Glyn ^a   Vordermeier, H Martin ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYTOKINE; INTERLEUKIN 4; ISONIAZID; BIOLOGICAL MARKER; INTERLEUKIN 4 VARIANT; INTERLEUKIN-4 VARIANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCG VACCINATION; BULLOCK; CATTLE DISEASE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; HEIFER; MALE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUBERCULIN TEST; TUBERCULOSIS; ANIMAL; BIOSYNTHESIS; CATTLE; DISEASE MODEL; IMMUNOLOGY; METABOLISM; PATHOGENICITY;

ANIMALS; BCG VACCINE; BIOLOGICAL MARKERS; CATTLE; CYTOKINES; DISEASE MODELS, ANIMAL; INTERLEUKIN-4; MYCOBACTERIUM BOVIS; TUBERCULIN TEST; TUBERCULOSIS VACCINES; TUBERCULOSIS, BOVINE;

EID: 34249883554     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01932-06     Document Type: Article

References (39)

1. + T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice. Infect. Immun. 68:621-629.
2. Atamas, S. P., J. Choi, V. V. Yurovsky, and B. White. 1996. An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation. J. Immunol 156:435-441.
3. + lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Arthritis Rheum. 42:1168-1178.
4. Biedermann, T., S. Zimmermann, H. Himmelrich, A. Gumy, O. Egeter, A. K. Sakrauski, I. Seegmuller, H. Voigt, P. Launois, A. D. Levine, H. Wagner, K. Heeg, J. A. Louis, and M. Rocken. 2001. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat. Immunol. 2:1054-1060.
5. Buddle, B. M., F. E. Aldwell, M. A. Skinner, G. W. deLisle, M. Denis, H. M. Vordermeier, R. G. Hewinson, and D. N. Wedlock. 2005. Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis. Vaccine 23:3581-3589.
6. Buddle, B. M., D. Keen, A. Thomson, G. Jowett, J. Heslop, G. W. deLisle, and J. L. Stanford. 1995. Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route but not by vaccination with killed Mycobacterium vaccae. Res. Vet. Sci. 59:10-16.
7. Charlei, D., S. Mostowy, D. Alexander, L. Sit, H. G. Wiker, and M. A. Behr. 2005. Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK. Mol. Microbiol. 56:1302-1313.
8. Dean, G. S., S. G. Rhodes, M. Coad, A. O. Whelan, P. J. Cockle, D. J. Clifford, R. G. Hewinson, and H. M. Vordermeier. 2005. Minimum infective dose of Mycobacterium bovis in cattle. Infect. Immun. 73:6467-6471.
9. de Jong, R., F. Altare, I. A. Haagen, D. G. Elferink, T. Boer, P. J. van Breda Vriesman, P. J. Kabel, J. M. Draaisma, J. T. van Dissel, F. P. Kroon, J. L. Casanova, and T. H. Ottenhoff. 1998. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280:1435-1438.
10. Demissie, A., M. Abebe, A. Aseffa, G. Rook, H. Fletcher, A. Zumla, K. Weldingh, I. Brock, P. Andersen, M. Doherty, and the VACSEL Study Group. 2004. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4δ2. J. Immunol. 172:6938-6943.
11. Demissie, A., L. Wassie, M. Abebe, A. Aseffa, G. Rook, A. Zumla, P. Andersen, T. M. Doherty, and the VACSEL Study Group. 2006. The 6-kilodalton early secreted antigenic target-responsive asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon. Infect. Immun. 74:2817-2822.
12. Dheda, K., J. S. Chang, R. A. M. Breen, A. Jamanda, J. A. Haddock, M. Lipman, L. U. Kim, J. F. Huggett, M. A. Johnson, G. A. W. Rook, and A. Zumla. 2005. Expression of a novel cytokine, IL4delta2, in HIV and HIV-tuberculosis co-infection. AIDS 19:1601-1606.
13. European Economic Community. 1980. EEC directive 80/219 EEC, amending directive 64/432 annexe B. Off. J. L047:25-32.
14. Fletcher, H., P. Owiafe, D. Jeffries, P. Hill, G. A. W. Rook, A. Zumla, T. M. Doherty, R. H. Brookes, and the VACSEL Study Group. 2004. Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4δ2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation. Immunology 112:669-673.
15. + T cells, resulting in a state of unresponsiveness to IL-12. J. Immunol. 161:6156-6163.
16. Howard, A. D., and B. S. Zwilling. 1999. Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines. Clin. Exp. Immunol. 115:428-434.
17. Huygen, K., D. Abramovicz, P. Vandenbussche, F. Jacobs, J. DeBruyn, A. Kentos, A. Drowart, J.-P. Van Voornen, and M. Goldman. 1992. Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect. Immun. 60:2880-2886.
18. Jouanguy, E., S. Lamhamedi-Cherradi, D. Lammas, S. E. Dorman, M. C. Fondaneche, S. Dupuis, R. Doffinger, F. Altare, J. Girdlestone, J. F. Emilie, H. Ducoulombier, D. Edgar, J. Clarke, V. A. Oxelius, M. Brai, V. Novelli, K. Heyne, A. Fischer, S. M. Holland, D. S. Kumararatne, R. D. Schreiber, and J. L. Casanova. 1999. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat. Genet. 21:370-378.
19. Kindler, V., A. P. Sappine, G. E. Grau, P. F. Piguet, and P. Vassalli. 1989. The inducing role of tumour necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740.
20. Langennegger, J., M. I. Cavalcante, and A. Lira. 1991. Treatmento missal da tubercolose bovina com isoniazida. Pesqui. Vet. Bras. 11:21-23.
21. Leite, R. M. H., R. C. Leite, J. A. Lima, C. B. Foscolo, P. M. P. C. Mota, F. C. F. Lobato, and A. P. Lage. 2000. HPLC identification of isoniazid residues in bovine milk. Arq. Bras. Med. Vet. Zootec. 52:662-668.
22. Leutenegger, C. M., A. M. Alluwaimi, W. L. Smith, L. Perani, and J. S. Cullor. 2000. Quantitaion of bovine cytokine mRNA in milk cells of healthy cattle by real-time Taqman polymerase chain reaction. Vet. Immunol. Immunopathol. 77:275-287.
23. Lopez, A. J. 1998. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. Annu. Rev. Genet. 32:279-305.
24. Mendez-Samperio, P., A. Badilo-Flores, A. Nunez-Vazquez, and M. Hernandez-Garay. 1997. Interleukin-4 inhibits secretion of IL-1 beta in the response of human cells to mycobacterial heat shock proteins. Clin. Diagn. Lab. Immunol. 4:665-670.
25. + T regulatory cell-mediated suppression. J. Immunol. 174:7645-7653.
26. Rhodes, S. G., N. Palmer, S. P. Graham, A. E. Bianco, R. G. Hewinson, and H. M. Vordermeier. 2000. Distinct response kinetics of gamma-interferon and interleukin-4 in bovine tuberculosis. Infect. Immun. 68:5393-5400.
27. Rook, G. A. W., R. Hernandez-Pando, K. Dheda, and G. Teng Seah. 2004. IL-4 in tuberculosis: implications for vaccine design. Trends Immunol. 25:483-488.
28. + CD4+ precursors. J. Immunol. 175:6107-6116.
29. Skinner, M. A., B. M. Buddle, D. N. Wedlock, D. Keen, G. W. deLisle, R. E. Tascon, J. C. Ferraz, D. B. Lowrie, P. J. Cockle, H. M. Vordermeier, and R. G. Hewinson. 2003. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis. Infect. Immun. 71:4901-4907.
30. Standiford, T. J., R. M. Streiter, S. W. Chensue, J. Westwick, K. Ka-sahara, and S. L. Kunkel. 1990. IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J. Immunol. 145:1435-1439.
31. Suazo, F. M., A. M. Escalera, and R. M. Torres. 2003. A review of M. bovis BCG protection against TB in cattle and other animal species. Prev. Vet. Med. 58:1-13.
32. te Velde, A. A., R. J. F. Huijbens, K. Heye, J. E. De Vries, and C. G. Figdor. 1990. Interleukin-4 (IL-4) inhibits secretion of IL-1β, tumour necrosis factor-α and IL-6 by human monocytes. Blood 76:1392-1397.
33. van Pinxteren, L. A., J. P. Cassidy, B. H. Smedegaard, E. M. Agger, and P. Andersen. 2000. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur. J. Immunol. 30:3689-3698.
34. Vordermeier, H. M., M. A. Chambers, P. J. Cockle, A. O. Whelan, J. Simmons, and R. G. Hewinson. 2002. Correlation of ESAT6-specific gamma-interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun. 70:3026-3032.
35. Waldvogel, A. S., M.-F. Lepage, A. Zakher, M. P. Reichel, R. Eicher, and V. T. Heussler. 2004. Expression of interleukin-4, interleukin-4 splice variants and interferon-gamma mRNA in calves experimentally infected with Fasciola hepatica. Vet. Immunol. Immunopathol. 97:53-63.
36. Wedlock, D. N., M. Denis, M. A. Skinner, J. Koach, G. W. deLisle, H. M. Vordermeier, R. G. Hewinson, S. van Drunen Little-van den Hurk, L. A. Babiuk, R. Hecker, and B. M. Buddle. 2005. Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone. Infect. Immun. 73:3540-3546.
37. Wedlock, D. N., M. A. Skinner, G. W. deLisle, H. M. Vordermeier, R. G. Hewinson, R. Hecker, S. van Drunen Little-van den Hurk, L. A. Babiuk, and B. M. Buddle. 2005. Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis. Vet. Immunol. Immunopathol. 106:53-63.
38. Wertheim, W. A., S. L. Kunkel, T. J. Standiford, M. D. Burdick, F. S. Becker, C. A. Wilkie, A. R. Gilbert, and R. M. Streiter. 1993. Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. J. Immunol. 151:2166-2175.
39. Zamboni, P., D. Conte, and V. Cuomo. 1979. Antituberculars, antibiotics, farmacology, p. 161-170. Adriatica, Bari, Italy.